Yangxinshi Tablet Improves Exercise Capacity for Patients with Coronary Heart Disease: Results from a Randomized, Double-Blind, Placebo-Controlled, and Multicenter Trial

Yangxinshi Tablet Improves Exercise Capacity for Patients with Coronary Heart Disease: Results from a Randomized, Double-Blind, Placebo-Controlled, and Multicenter Trial

Objective: To assess the clinical effectiveness of Yangxinshi (YXS) tablets on exercise capacity and symptoms of anxiety and depression in patients with coronary heart disease (CHD). Methods and Results: A randomized, double-blind, placebo-controlled, multicenter clinical trial was performed to asse...

Full description

Bibliographic Details
Main Authors: Sisi Zhang, Yuqin Shen, Peiliang Liu, Xiaoping Meng, Dayi Hu
Format: Article
Language:English
Published: IMR Press 2022-07-01
Series:Reviews in Cardiovascular Medicine
Subjects:
yangxinshi tablets
coronary heart disease
exercise capacity
anxiety and depression
Online Access:https://www.imrpress.com/journal/RCM/23/8/10.31083/j.rcm2308266

Internet

https://www.imrpress.com/journal/RCM/23/8/10.31083/j.rcm2308266

Similar Items